Plunkett Research Online: Veracyte Inc

VERACYTE INC (VCYT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against the diseases such as thyroid cancer, lung cancer etc. The firm's product portfolio consists of products such as Afirma analysis, Percepta classifier and Envisia classif.....



Veracyte Inc
Ticker: VCYT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 243-6300
Fax: 650 243-6388
Address: 6000 Shoreline Court
Suite 300
South San Francisco, CA 94080 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Bonnie AndersonCEO/Director/Chairman of the Board
Keith KennedyCFO/Chief Accounting Officer/Secretary
See More
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against the diseases such as thyroid cancer, lung cancer etc. The firm's product portfolio consists of products such as Afirma analysis, Percepta classifier and Envisia classif.....See More See More

Auditor: ERNST & YOUNG, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: